NCT06295861View on ClinicalTrials.gov

Prospective Cohort Study of Panvascular Disease

Active, not recruitingOBSERVATIONAL
Enrollment

50,000

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

November 30, 2028

Study Completion Date

December 31, 2028

Conditions
ASCVD
Interventions
OTHER

no different intervention between the two cohort.

no different intervention between the two cohort.

Trial Locations (2)

310000

Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06295861 - Prospective Cohort Study of Panvascular Disease | Biotech Hunter | Biotech Hunter